HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Yousfi Tarek, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria

A series of new isoxazolidine and pyrazolidine compounds were synthesized in very good yields of 76-99.2% by Michael and Aza-Michael reactions, respectively, and all compounds were characterized by 1H NMR, 13C NMR. we discovered that the pyrrolidine/benzoic acid catalyzed in Mich [....] » Read More

Awranoos Ahadi, Speaker at Immunology Conferences
Poster Presentation (In-person)
Awranoos Ahadi, Bolan Medical College, Pakistan

Background: The Eastern Mediterranean Region (EMRO) of the World Health Organization (WHO) is the last region in which polio transmission continues. Afghanistan and Pakistan, also being parts of South Asia, pose a major burden for the transmission of the virus both in the EMRO an [....] » Read More

Temesgen Azemeraw Yitayew, Speaker at Vaccine Research Conference
Poster Presentation (In-person)
Temesgen Azemeraw Yitayew, Addis Ababa University, Ethiopia

Primary HPV testing and triage of HPV – positive women is an effective cervical cancer screening strategy. Such a multi-visit screening algorithm is also promising for community based screening in resource-poor communities, provided a robust tracking system is in place.&nbs [....] » Read More

Attahir Abubakar, Speaker at Vaccines meetings
Poster Presentation (In-person)
Attahir Abubakar, Ahmadu Bello University , Nigeria

This study examines the awareness and acceptability of the rotavirus vaccine among mothers of children under five in Gusau and Bungudu, Zamfara State, Nigeria. Employing a comparative cross-sectional design, the research utilized quantitative surveys and qualitative focus groups [....] » Read More

Scientific Programs coming soon..

Elena Chiappini, Speaker at Immunology Conferences
Oral Presentation (Virtual)
Elena Chiappini, University of Florence, Italy

Background: Paediatric tuberculosis (TB) represents a critical health concern due to the significant risk of extrapulmonary TB (EPTB), severe disease forms, and the increasing prevalence of drug-resistant strains (DR-TB). Understanding the clinical characteristics of affected chi [....] » Read More

Yacob Mathai, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Yacob Mathai, Marma Health Centre, India

If the body becomes inflamed after consuming a substance, our immune system tells us that the substance is against the body.  If the substance further increases inflammation, reduces blood flow, and affects organ function, the substance is life-threatening.  Vaccinat [....] » Read More

Ahmed Abdulazeez, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Ahmed Abdulazeez, BHRUT Trust, United Kingdom

This study aims to review the available data regarding the central role of immunity in combating SARS-CoV-2 infection and in the generation of protection by vaccination against COVID-19 in different age groups. Physiologically, the immune response and the components involved in i [....] » Read More

Livia Daflon Silva, Speaker at Cancer Vaccines Congress
Oral Presentation (Virtual)
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil

Introduction: In Brazil, the 10-valent and 23-valent pneumococcal vaccines are available free of charge and are the most common pneumococcal vaccines administered. These vaccines play a key role in preventing severe bacterial infections caused by Streptococcus pneumoniae. However [....] » Read More

K R Aneja, Speaker at Immunotherapy Conferences
Oral Presentation (Virtual)
K R Aneja, Kurukshetra University, India

The incidence of fungal infections, called mycosis, has dramatically increased in COVID-19 patients with predisposing factors. COVID-19, not over and still circulating worldwide, is a respiratory illness caused by strains of coronavirus SARS-CoV-2 (severe acute respiratory syndro [....] » Read More

Watsapp